Legal Representation
Attorney
Thomas J. Perkowski
USPTO Deadlines
Next Deadline
81 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
October 18, 2025
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 1, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 1, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 14, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 11, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Nov 18, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Nov 18, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 18, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 18, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Nov 18, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Nov 18, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Oct 18, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 17, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 17, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 17, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 8, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 8, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 20, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Nov 20, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Nov 20, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Nov 20, 2023 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Nov 20, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Nov 20, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 20, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 18, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 23, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 21, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 21, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 18, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 23, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 23, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 3, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 18, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 13, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 12, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 12, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 13, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 13, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 15, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 8, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Gels and ointments for ophthalmic use, namely, ophthalmic gel and ointment preparation for promoting eye health and human vision for optimum eye function; Artificial tears, namely, artificial tears in gel and ointment form for the provision of ocular surface lubrication; Vitamin supplements for promoting optimal tear film supplementation, osmolarity and stability; Food supplements, namely, anti-oxidants for promoting optimal tear film supplementation, osmolarity and stability; Nutritional supplements containing fatty acids for promoting optimal tear film supplementation, osmolarity and stability; Nutritional supplements comprising vitamins, antioxidants and fatty acids for promoting optimal tear film supplementation, osmolarity and stability; Gels and ointments for ophthalmic use, namely, ophthalmic sterile gel and ointment for osmoprotection, thermoregulation and anti-inflammation of tear film, ocular surface, eyelids and eyelashes; Gels and ointments for ophthalmic use, namely, ophthalmic eye gel and ointment for eyelid exfoliation, optimization of meibomian gland function and promoting eyelid function; Artificial tears, namely, preservative-free artificial tears preparations in sterile ophthalmic gel and ointment form for preserving the ocular surface
Classification
International Classes
005